APOE and Alzheimer disease: Several recent studies that linked APOE ε4 status to relatively late risk of preclinical progression to AD (e.g., Lane et al., 2008; Barabash et al., 2009; Elias-Sonnenschein et al., 2011; Reinvang et al., 2013).